6-carbamoyl-9-(2'-hydroxyethyl)-2-phenylpurine | 144486-63-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 6-carbamoyl-9-(2'-hydroxyethyl)-2-phenylpurine
• 英文别名: 9-(2-Hydroxyethyl)-2-phenylpurine-6-carboxamide
• CAS: 144486-63-5
• 化学式: C₁₄H₁₃N₅O₂
• 分子量: 283.29
• InChiKey: MWKDGWKQVQCNGG-UHFFFAOYSA-N

物化性质

• 沸点：
  505.6±60.0 °C(Predicted)
• 密度：
  1.50±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  107
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  ethyl (Z)-N-(2-amino-1,2-dicyanovinyl)formamidate 在 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 乙醇 、 乙酸乙酯 、 乙腈 为溶剂， 反应 1012.0h， 生成 6-carbamoyl-9-(2'-hydroxyethyl)-2-phenylpurine
  参考文献：
  名称：

  Booth, Brian L.; Dias, Alice M.; Proenca, M. Fernanda, Journal of the Chemical Society. Perkin transactions I, 1992, # 16, p. 2119 - 2126

  摘要：

  DOI：

文献信息

• Heteroaryl compounds, compositions thereof, and methods of treatment therewith
  申请人：Mortensen Deborah Sue

  公开号：US20090042890A1

  公开（公告）日：2009-02-12

  Provided herein are Heteroaryl Compounds having the following structure: wherein R 1 , R 3 , R 4 , L, X, Y, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.

  提供以下结构的杂环芳基化合物：其中R1、R3、R4、L、X、Y、A和B的定义如下，包括有效量的杂环芳基化合物的组合物以及用于治疗或预防癌症、炎症性疾病、免疫疾病、代谢疾病以及可通过抑制激酶途径治疗或预防的疾病的方法，包括向需要治疗的患者中给予有效量的杂环芳基化合物。
• METHODS OF TREATMENT USING HETEROARYL COMPOUNDS AND COMPOSITIONS THEREOF
  申请人：Mortensen Deborah Sue

  公开号：US20110224217A1

  公开（公告）日：2011-09-15

  Provided herein are Heteroaryl Compounds having the following structure: wherein R 1 , R 3 , R 4 , L, X, Y, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.

  本文提供具有以下结构的杂环芳基化合物：其中R1、R3、R4、L、X、Y、A和B的定义如本文所述，包含有效量的杂环芳基化合物的组合物以及治疗或预防癌症、炎症性疾病、免疫疾病、代谢性疾病以及可通过抑制激酶通路治疗或预防的疾病的方法，包括向需要治疗的患者投与有效量的杂环芳基化合物。
• HERBICIDAL COMPOUNDS
  申请人：Whittingham William Guy

  公开号：US20120202690A1

  公开（公告）日：2012-08-09

  The present invention relates to substituted heterobicyclic carboxylic acid derivatives, as well as N-oxides and agriculturally acceptable salts thereof, and their use in controlling plant growth, particularly undesirable plant growth, in crops of useful plants. The invention extends to herbicidal compositions comprising such compounds, N-oxides and/or salts as well as mixtures of the same with one or more further active ingredients and/or a safener.

  本发明涉及取代的杂双环羧酸衍生物，以及其N-氧化物和农业上可接受的盐，以及它们在控制植物生长方面的应用，特别是在有用植物的作物中控制不良植物生长。该发明还涉及包含这些化合物、N-氧化物和/或盐以及与一种或多种其他活性成分和/或安全剂混合的除草剂组合物。
• Treatment of cancer with TOR kinase inhibitors
  申请人：Signal Pharmaceuticals, LLC

  公开号：US11166950B2

  公开（公告）日：2021-11-09

  Provided herein are methods for treating or preventing a solid tumor, non-Hodgkin lymphoma or multiple myeloma in a patient, comprising administering an effective amount of a TOR kinase inhibitor to a patient having a solid tumor, non-Hodgkin lymphoma or multiple myeloma.

  本文提供了治疗或预防患者实体瘤、非霍奇金淋巴瘤或多发性骨髓瘤的方法，包括向患有实体瘤、非霍奇金淋巴瘤或多发性骨髓瘤的患者施用有效量的TOR激酶抑制剂。
• HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS
  申请人：Signal Pharmaceuticals LLC

  公开号：EP2078018A1

  公开（公告）日：2009-07-15